fall 2019 innovator dr holers in laboratory

Innovator Spotlight - Michael Holers, MD

Gain insights for successfully delivering cures into the hands of patients from one of the leading innovators on the CU Anschutz Medical Campus. 

digital global graph funding

$10 Million in Funding Goes to IM Therapeutics

IM Therapeutics receives $10M Series A to advance discovery platform and diabetes drug development. 


CU Anschutz Awarded Grant to Advance Academic Discoveries

The University of Colorado Anschutz Medical Campus has been awarded $4 million over the next four years from the National Institutes of Health (NIH) Research Evaluation and Commercialization Hubs (REACH) grant.